Carolyn Krasner

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

Bradley J. Monk, Thomas J. Herzog, Stanley B. Kaye et al. · Journal of Clinical Oncology · 2010 · 404 citations

Medicine, Gynecology, Oncology +16

Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer

Ursula A. Matulonis, Suzanne Berlin, Percy Ivy et al. · Journal of Clinical Oncology · 2009 · 301 citations · Full text

Medicine, Oncology, Pharmacology +11

Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer

Panagiotis A. Konstantinopoulos, Weixiu Luo, Joyce F. Liu et al. · Journal of Clinical Oncology · 2019 · 218 citations · Full text

Medicine, Immunology, Oncology +17

Long‐term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer

Alice B. Kornblith, Mark Powell, Meredith M. Regan et al. · Psycho-Oncology · 2007 · 215 citations

Medicine, Oncology, Geriatric Assessment +5

Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma

Joyce F. Liu, Niya Xiong, Susana M. Campos et al. · Journal of Clinical Oncology · 2021 · 195 citations

Medicine, Oncology, Pharmacology +17